Clinical Trial Update: Comparison of Hematocrit Levels in Infant Heart Surgery [Phase 3]

View source ↗

Summary

The update notes completion of a Phase 3 clinical trial evaluating hematocrit level management during infant heart surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Congenital Heart Defects
• Heart Diseases
• Transposition of the Great Arteries

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED